Profile | GDS4284 / 202062_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 498.263 | 64 |
GSM687648 | Patient 402 control | 405.948 | 61 |
GSM687653 | Patient 403 control | 497.649 | 64 |
GSM687658 | Patient 404 control | 611.776 | 67 |
GSM687663 | Patient 411 control | 603.443 | 66 |
GSM687668 | Patient 422 control | 581.424 | 66 |
GSM687673 | Patient 424 control | 586.39 | 65 |
GSM687678 | Patient 425 control | 564.254 | 65 |
GSM687683 | Patient 427 control | 396.875 | 59 |
GSM687688 | Patient 428 control | 784.605 | 70 |
GSM687695 | Patient 441 control | 706.472 | 69 |
GSM687699 | Patient 443 control | 916.17 | 72 |
GSM687704 | Patient 444 control | 772.023 | 70 |
GSM687707 | Patient 448 control | 1152.47 | 77 |
GSM687712 | Patient 449 control | 745.711 | 70 |
GSM687719 | Patient 450 control | 618.819 | 66 |
GSM687724 | Patient 451 control | 703.953 | 69 |
GSM687728 | Patient 452 control | 657.734 | 68 |
GSM687646 | Patient 401 treated 24h | 507.255 | 63 |
GSM687649 | Patient 402 treated 24h | 443.508 | 62 |
GSM687665 | Patient 411 treated 24h | 628.801 | 66 |
GSM687651 | Patient 402 treated 4 weeks | 561.911 | 65 |
GSM687667 | Patient 411 treated 4 weeks | 543.245 | 64 |
GSM687670 | Patient 422 treated 24h | 704.555 | 68 |
GSM687671 | Patient 422 treated 4 weeks | 798.382 | 70 |
GSM687654 | Patient 403 treated 24h | 477.788 | 64 |
GSM687675 | Patient 424 treated 24h | 589.592 | 65 |
GSM687685 | Patient 427 treated 24h | 481.823 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 629.113 | 67 |
GSM687677 | Patient 424 treated 4 weeks | 584.361 | 66 |
GSM687687 | Patient 427 treated 4 weeks | 658.393 | 67 |
GSM687692 | Patient 428 treated 4h | 688.581 | 68 |
GSM687716 | Patient 449 treated 4h | 1034.31 | 75 |
GSM687722 | Patient 450 treated 4h | 463.57 | 61 |
GSM687680 | Patient 425 treated 24h | 627.321 | 67 |
GSM687690 | Patient 428 treated 24h | 521.971 | 65 |
GSM687700 | Patient 443 treated 24h | 696.736 | 67 |
GSM687705 | Patient 444 treated 24h | 938.51 | 73 |
GSM687714 | Patient 449 treated 24h | 636.903 | 68 |
GSM687721 | Patient 450 treated 24h | 734.719 | 69 |
GSM687682 | Patient 425 treated 4 weeks | 499.321 | 64 |
GSM687694 | Patient 428 treated 4 weeks | 483.505 | 63 |
GSM687702 | Patient 443 treated 4 weeks | 567.232 | 64 |
GSM687718 | Patient 449 treated 4 weeks | 773.872 | 71 |
GSM687723 | Patient 450 treated 4 weeks | 503.623 | 63 |
GSM687661 | Patient 404 treated 4h | 538.782 | 64 |
GSM687710 | Patient 448 treated 4h | 1025.45 | 75 |
GSM687726 | Patient 451 treated 4h | 1159.38 | 76 |
GSM687730 | Patient 452 treated 4h | 189.223 | 32 |
GSM687660 | Patient 404 treated 24h | 467.787 | 63 |
GSM687697 | Patient 441 treated 24h | 1580.82 | 82 |
GSM687709 | Patient 448 treated 24h | 1121.34 | 76 |
GSM687725 | Patient 451 treated 24h | 1154.63 | 76 |
GSM687729 | Patient 452 treated 24h | 899.756 | 74 |
GSM687727 | Patient 451 treated 4 weeks | 1524.73 | 80 |
GSM687731 | Patient 452 treated 4 weeks | 886.406 | 72 |